Clinical Trial

A Food Effect Study of LY03020 in Healthy Subjects

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, open-label, single-dose, two-period, crossover study to assess the food effect on pharmacokinetics (PK) and safety of LY03020 in healthy subjects.
Trial Details
NCT Number NCT07292233
Lead Sponsor Luye Pharma Group Ltd.
Conditions Schizophrenia, Alzheimer's Disease Psychosis
Enrollment 16 participants
Start Date 2025-07-30
Primary Completion 2025-08-27 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-18